Go to main page

Symposium: Innovative Approaches to Accelerating Drug Discovery and Development

Thursday, March 22, 2018 from 12:00 PM to 6:00 PM (PST)

South San Francisco, CA

Register Today!
pic1

How can we accelerate successful drug discovery and development?

The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.

Join us on Thursday, March 22, 2018 for an afternoon of lunch, insightful presentations and discussion, followed by a networking and happy hour reception.

BioDuro invites you to hear from industry experts on:

From Small Fragments to Big Drugs: Fragment-based Drug Discovery
Dan Erlanson, Ph.D | Co-founder and VP of Chemistry | Carmot Therapeutics

From Fragments to Drugs: Playing Quick Molecular Scrabble with Protein Crystallography
Debanu Das, Ph.D | Co-founder and CEO | Accelero Biostructures

Role of DMPK in Drug Discovery and Development
JP Shaw, Ph.D | Independent Pre-Clinical DMPK Consultant

Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models 
Tommy Broudy, Ph.D | CEO | Molecular Response

Non-Toxic Pre-Clinical Formulations for Insoluble Compounds: Applying Enabled Formulations Approaches to Late Phase Discovery
Blair West, Ph.D | Chief Science Officer, Global CMC Solutions | BioDuro

Rapid Development and Scale-up of Solubilized Dosage Forms
Ruchit Trivedi, Ph.D | Associate Director, Formulation | BioDuro

Registration for this event is free, but space is limited. RSVP here!

We look forward to seeing you in San Francisco!

Event Details:

Date:

Thursday, March 22, 2018
11:30 PM- 6:00 PM PDT

 

Location:

Hilton Garden Inn, San Francisco Airport North
670 Gateway Blvd
South San Francisco, CA 94080

Agenda:

11:30- 12:30 PM

Registration & Lunch, Opening Remarks

12:30 PM- 1:10 PM

From Small Fragments to Big Drugs: Fragment-based Drug Discovery
Dan Erlanson, PhD | Co-founder and VP of Chemistry | Carmot Therapeutics

1:10 PM- 1:50 PM

From Fragments to Drugs: Playing Quick Molecular Scrabble with Protein Crystallography
Debanu Das, PhD | Co-founder and CEO | Accelero Biostructures

1:50 PM- 2:00 PM

Break

2:00 PM- 2:40 PM

Role of DMPK in Drug Discovery and Development
JP Shaw, PhD | Independent Pre-Clinical DMPK Consultant

2:40 PM- 3:20 PM

Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models 
Tommy Broudy, PhD | CEO | Molecular Response

3:20 PM- 3:30 PM

Break

3:30 PM- 4:10 PM

Non-Toxic Pre-Clinical Formulations for Insoluble Compounds: Applying Enabled Formulations Approaches to Late Phase Discovery
Blair West, PhD | Chief Science Officer, Global CMC Solutions | BioDuro

4:10 PM- 4:50 PM

Rapid Development and Scale-up of Solubilized Dosage Forms
Ruchit Trivedi, PhD | Associate Director, Formulation | BioDuro

4:50- 5:00 PM

Closing Remarks & Raffle – Airbnb Getaway (must be present to win!)

5:00 PM- 6:30 PM

Networking Reception and Happy Hour

Registration:

This event is free to attend, but space is limited. Reserve a seat today!

If you have any questions about this event, please contact us directly.